Ten-year survival of children with trisomy 13 or trisomy 18: a multi-registry European cohort study

Svetlana V Glinianaia1, Judith Rankin2, Joachim Tan3

  • 1Newcastle University Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK svetlana.glinianaia@ncl.ac.uk.

Insights

Survival rates for children with trisomy 13 (T13) and trisomy 18 (T18) show that a significant portion, 32% and 21% respectively, can live to age 10 if they survive the first four weeks. These findings aid in counseling families after prenatal diagnosis.

Area of Science:

  • Genetics and Genomics
  • Pediatric Medicine
  • Public Health Surveillance

Background:

  • Trisomy 13 (T13) and Trisomy 18 (T18) are severe chromosomal abnormalities associated with high neonatal mortality.
  • Accurate survival data is crucial for parental counseling and clinical management.

Purpose of the Study:

  • To determine the long-term survival rates up to 10 years of age for children diagnosed with T13 or T18.
  • To provide updated survival estimates for clinical and familial guidance.

Main Methods:

  • A population-based cohort study utilizing linked mortality data from 13 European registries (EUROCAT network).
  • Inclusion of live births with T13 or T18, including translocations and mosaicisms, between 1995 and 2014.
  • Survival estimates calculated using random-effects meta-analyses of Kaplan-Meier survival data.

Main Results:

  • Estimated survival for T13: 34% at 4 weeks, 17% at 1 year, and 11% at 10 years.
  • Estimated survival for T18: 38% at 4 weeks, 13% at 1 year, and 8% at 10 years.
  • Conditional 10-year survival for those surviving to 4 weeks: 32% for T13 and 21% for T18.

Conclusions:

  • Despite high neonatal mortality, a substantial proportion of infants with T13 and T18 who survive the neonatal period can live to 10 years.
  • These survival estimates offer valuable information for genetic counseling following prenatal diagnosis of T13 or T18.
Abstract

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
407
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.6K
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
106
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
263